Monoclonal Antibodies (Mabs) Market Poised for Disruptive Growth by 2032
The global monoclonal antibodies market was valued at USD 185.07 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.5% during the forecast period. The market's growth is driven by increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases, along with rising adoption of targeted therapies. Key Market...
0 Comentários 0 Compartilhamentos 907 Visualizações